Lansoprazole Capsule, Delayed Release Pellets
Product Images NDC 51079-121

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 51079-121). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Structural Formula (Image 01)

Chemical structure diagram of lansoprazole, showing the molecular arrangement with sulfur, nitrogen, oxygen, carbon, hydrogen atoms and characteristic functional groups as depicted.*

FDA Label Image

Lansoprazole Delayed-release 30 mg Capsules Unit Carton Label (Image 02)

A line graph showing mean severity of day heartburn over time for patients treated with placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. The x-axis represents days from start of treatment, and the y-axis shows mean severity of day heartburn on a scale from 0 (none) to 3 (severe). Lansoprazole groups show a faster reduction in severity compared to placebo over approximately 60 days.*

FDA Label Image

Unit Carton (Image 03)

A line graph showing the mean severity of night heartburn over days from the start of treatment for patients. It compares three groups: Placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily, with severity measured on a scale from 0 (None) to 3 (Severe). The graph illustrates trends in symptom severity reduction over approximately 60 days.*

FDA Label Image

Figure 1 (Image 04)

Label for Lansoprazole Delayed-Release Capsules, USP 30 mg, by Mylan Institutional Inc. The label shows the capsule imprint MYLAN 9030, product NDC 51079-121-08, and packaging for 80 capsules (8 x 10). It includes storage instructions and indicates the product is for oral use and prescription only.*

FDA Label Image

Figure 2 (Image 05)

The image shows a blue unit-dose package label for Lansoprazole 30 mg delayed-release pellets capsules. It includes warnings that the package is not child resistant and is for institutional use only. The label is distributed by Mylan Institutional Inc., Rockford, IL. A window displays the lot number and expiration date area.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.